Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Immunology Investigation Institute is a Japanese biotechnology company specializing in the development and manufacture of high-quality antibodies and diagnostic reagents for immunological research. The company focuses on providing tools for the detection and measurement of cytokines and other inflammatory markers, supporting both clinical diagnostics and basic life science research. Their product portfolio includes specialized enzyme-linked immunosorbent assay (ELISA) kits and monoclonal antibodies targeting key inflammatory mediators like Interleukin-6. By providing reliable analytical tools, the institute plays a critical role in the monitoring and study of autoimmune and inflammatory conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Immunology Investigation Institute.